Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000468787 | SCV000550113 | uncertain significance | Gastrointestinal stromal tumor | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 96 of the KIT protein (p.Thr96Met). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with KIT-related conditions. ClinVar contains an entry for this variant (Variation ID: 409773). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV001016873 | SCV001177874 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-01-14 | criteria provided, single submitter | clinical testing | The p.T96M variant (also known as c.287C>T), located in coding exon 2 of the KIT gene, results from a C to T substitution at nucleotide position 287. The threonine at codon 96 is replaced by methionine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
| Baylor Genetics | RCV000468787 | SCV004198090 | uncertain significance | Gastrointestinal stromal tumor | 2023-10-03 | criteria provided, single submitter | clinical testing |